IncRNA EPB41L4A-AS1 Mitigates the Proliferation of Non-Small-Cell Lung Cancer Cells through the miR-105-5p/GIMAP6

Bingwei Dong1, Fenjuan Zhang1, Weibo Zhang1

  • 1Department of Pathology, Xianyang Central Hospital, Xianyang City, 712000 Shaanxi Province, China.

Insights

Long non-coding RNA EPB41L4A-AS1 (lncRNA EPB41L4A-AS1) is downregulated in non-small-cell lung cancer (NSCLC). Overexpression of lncRNA EPB41L4A-AS1 inhibits NSCLC cell proliferation by regulating the miR-105-5p/GIMAP6 axis.

Area of Science:

  • Oncology
  • Molecular Biology
  • Genetics

Background:

  • Non-small-cell lung cancer (NSCLC) is the predominant form of lung cancer.
  • Long non-coding RNAs (lncRNAs), microRNAs (miRNAs), and proteins play critical roles in NSCLC pathogenesis.
  • Understanding the specific roles of these molecules is crucial for developing novel therapeutic strategies.

Purpose of the Study:

  • To investigate the function of lncRNA EPB41L4A-AS1 in NSCLC cell proliferation.
  • To elucidate the molecular mechanism involving lncRNA EPB41L4A-AS1, miR-105-5p, and GIMAP6 in NSCLC.
  • To provide a theoretical basis for NSCLC treatment.

Main Methods:

  • Quantitative real-time PCR (RT-qPCR) to measure lncRNA EPB41L4A-AS1, miR-105-5p, and GIMAP6 levels.
  • Cell counting kit-8 and colony formation assays to assess cell proliferation.
  • Dual-luciferase reporter and RNA pull-down assays to determine molecular interactions.
  • Subcellular fractionation and functional rescue experiments.

Main Results:

  • lncRNA EPB41L4A-AS1 and GIMAP6 were downregulated, while miR-105-5p was upregulated in NSCLC tissues and cells.
  • lncRNA EPB41L4A-AS1 expression correlated with tumor size and clinical stage.
  • lncRNA EPB41L4A-AS1 suppressed NSCLC cell proliferation by sponging miR-105-5p, thereby promoting GIMAP6 transcription.

Conclusions:

  • lncRNA EPB41L4A-AS1 acts as a tumor suppressor in NSCLC.
  • The lncRNA EPB41L4A-AS1/miR-105-5p/GIMAP6 axis is a key regulatory pathway in NSCLC proliferation.
  • Targeting this axis may offer a novel therapeutic approach for NSCLC.

Related Concept Videos

Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.6K
Mitogens and the Cell Cycle02:38

Mitogens and the Cell Cycle

Mitogens and their receptors play a crucial role in controlling the progression of the cell cycle. However, the loss of mitogenic control over cell division leads to tumor formation. Therefore, mitogens and mitogen receptors play an important role in cancer research. For instance, the epidermal growth factor (EGF) - a type of mitogen and its transmembrane receptor (EGFR), decides the fate of the cell's proliferation. When EGF binds to EGFR, a member of the ErbB family of tyrosine kinase...
6.6K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.4K